Filing Flows › Sotera Health (SHC) › Guidance history
Sotera Health (SHC) guidance history: what it guided and what it reported
Sotera Health gave guidance in 12 earnings releases on file since Aug 5, 2024. Its releases raised guidance 3 times and lowered it 5 times.
Revenue
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $1.2B–$1.3B (Feb 24, 2026) → reaffirmed $1.2B–$1.3B (May 5, 2026) → raised $1.2B–$1.3B (Aug 6, 2026) → lowered $1.2B–$1.2B (Nov 3, 2026) | — | to be reported | — |
Interest expense
This line is not in the statements Filing Flows reads, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $135M–$145M (Feb 24, 2026) → reaffirmed $135M–$145M (May 5, 2026) → lowered $135M–$142M (Aug 6, 2026) → reaffirmed $137M–$140M (Nov 3, 2026) | — | to be reported | — |
| FY2025 | $155M–$165M (Feb 27, 2025) → reaffirmed $155M–$165M (May 1, 2025) → reaffirmed $155M–$165M (Aug 8, 2025) → lowered $154M–$158M (Nov 4, 2025) | — | — | — |
| FY2024 | $165M–$175M (Aug 5, 2024) → reaffirmed $165M–$175M (Nov 5, 2024) | — | — | — |
Capital expenditures
The GAAP figure from the filings is shown for each period reported; it is not judged against the guide, which may leave items out (one-off payments, acquisitions).
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $175M–$225M (Feb 24, 2026) → reaffirmed $175M–$225M (May 5, 2026) → raised $200M–$225M (Aug 6, 2026) → reaffirmed $200M–$225M (Nov 3, 2026) | — | to be reported | — |
| FY2025 | $190M–$210M (Feb 27, 2025) → reaffirmed $190M–$210M (May 1, 2025) → lowered $170M–$180M (Aug 8, 2025) → lowered $125M–$135M (Nov 4, 2025) | $138M (GAAP) | not judged | — |
| FY2024 | $205M–$225M (Aug 5, 2024) → lowered $175M–$185M (Nov 5, 2024) | $179M (GAAP) | not judged | — |
Adjusted EPS
The guide is on an adjusted basis that the GAAP statements do not show, so there is no reported figure to hold it to.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $0.93–$1.01 (Feb 24, 2026) → reaffirmed $0.93–$1.01 (May 5, 2026) → raised $0.95–$1.01 (Aug 6, 2026) → reaffirmed $0.95–$1.01 (Nov 3, 2026) | — | to be reported | — |
| FY2025 | $0.70–$0.76 (Feb 27, 2025) → reaffirmed $0.70–$0.76 (May 1, 2025) → raised $0.75–$0.82 (Aug 8, 2025) → raised $0.81–$0.86 (Nov 4, 2025) | — | — | — |
| FY2024 | $0.67–$0.75 (Aug 5, 2024) → reaffirmed $0.67–$0.75 (Nov 5, 2024) | — | — | — |
Adjusted EBITDA
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $632M–$641M (Feb 24, 2026) → reaffirmed $632M–$641M (May 5, 2026) → raised $634M–$643M (Aug 6, 2026) → lowered $632M–$641M (Nov 3, 2026) | — | to be reported | — |
The latest quarter
Sotera Health, Q3 2026: revenue $325M (+4% year over year), operating margin 25.8%, net earnings $58.4M, operating cash flow $111M. The chart follows the revenue to costs, profit and cash.
Questions
Does Sotera Health beat its guidance?
Sotera Health gave guidance in 12 earnings releases on file since Aug 5, 2024. Its releases raised guidance 3 times and lowered it 5 times.
How often does Sotera Health raise guidance?
Its earnings releases raised guidance 3 times and lowered it 5 times since Aug 5, 2024.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.